|
Dataset 1
| | | | | |
|
CD4-Diversity \( \left(\overrightarrow{{}^{\alpha }D}\right) \): Month 2 versus Baseline + Month 12
|
86.5
|
72.9
|
100
|
0
|
8
|
|
CD4-Evenness \( \left(\overrightarrow{{}^{\alpha }E}\right) \): Month 2 versus Baseline + Month 12
|
91.7
|
83.3
|
100
|
0
|
11
|
|
CD8-Diversity \( \left(\overrightarrow{{}^{\alpha }D}\right) \): Month 2 versus Baseline + Month 12
|
79.2
|
58.3
|
100
|
0
|
9
|
|
CD8-Evenness \( \left(\overrightarrow{{}^{\alpha }E}\right) \): Month 2 versus Baseline + Month 12
|
96.9
|
93.8
|
100
|
0
|
6
|
|
Dataset 2
|
|
Diversity: Healthy versus CLL \( \left(\overrightarrow{{}^{\alpha }D}\right) \)
|
88
|
77
|
100
|
0
|
5
|
|
Evenness: Healthy versus CLL \( \left(\overrightarrow{{}^{\alpha }E}\right) \)
|
84
|
77
|
91
|
0
|
2
|
